Pharmacokinetic/pharmacodynamic model for the time course of myelosuppression of new anticancer drug (CKD-602)

MLA

Yi, S. Y., et al. Pharmacokinetic/Pharmacodynamic Model for the Time Course of Myelosuppression of New Anticancer Drug (CKD-602). EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..123013578df2344caed59de32a973c1c&authtype=sso&custid=ns315887. Accessed 9 Mar. 2025.

APA

Yi, S.-Y., Jang, I.-J., Bae, K.-S., Joo-Youn Cho, Yu, K.-S., Lim, H.-S., Chung, J.-Y., Hong, K.-S., Bang, Y.-J., & Shin, S.-G. (n.d.). Pharmacokinetic/pharmacodynamic model for the time course of myelosuppression of new anticancer drug (CKD-602).

Chicago

Yi, S. -Y, I. -J Jang, K. -S Bae, Joo-Youn Cho, K. -S Yu, H. -S Lim, J. -Y Chung, K. -S Hong, Y. -J Bang, and S. -G Shin. 2025. “Pharmacokinetic/Pharmacodynamic Model for the Time Course of Myelosuppression of New Anticancer Drug (CKD-602).” Accessed March 9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..123013578df2344caed59de32a973c1c&authtype=sso&custid=ns315887.